Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
13.81%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 2.93Close
$ 1.33 - $ 4.01 52-Week Range
Ticker Information
Ticker
AKBACompany Name
AKEBIA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQAKEBIA THERAPEUTICS INC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
AKBA - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 28.14M | 13.81% | $ 203.73M |
| 3/31/2025 | $ 23.46M | 12.69% | $ 184.91M |
| 12/31/2024 | $ 18.18M | 11.35% | $ 160.18M |
| 9/30/2024 | $ 12.73M | 7.49% | $ 169.88M |
| 6/30/2024 | $ 7.47M | 4.28% | $ 174.5M |
| 3/31/2024 | $ 6.97M | 3.72% | $ 187.22M |
| 12/31/2023 | $ 6.03M | 3.1% | $ 194.62M |
| 9/30/2023 | $ 6.25M | 3.23% | $ 193.61M |
| 6/30/2023 | $ 8.79M | 4.38% | $ 200.53M |
| 3/31/2023 | $ 12.19M | 4.5% | $ 271.03M |
Key Performance Insights, Last 5 Years
- AKEBIA THERAPEUTICS INC's latest trailing twelve months (TTM) Int. Exp. % stands at 2.13%.
- Over the past 5 years, AKEBIA THERAPEUTICS INC's average Int. Exp. % has been 6.49%.
- The median Int. Exp. % for AKEBIA THERAPEUTICS INC during this period was 5.9%
- AKEBIA THERAPEUTICS INC reached its highest Int. Exp. % over the past 5 years at 13.81%.
- The lowest Int. Exp. % recorded by AKEBIA THERAPEUTICS INC in the same timeframe 2.13%
AKEBIA THERAPEUTICS INC's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for AKEBIA THERAPEUTICS INC is calculated as follows: Int. Exp. [ $ 6.55M ] / Revenues [ $ 308.16M ]
(=) Int. Exp. % [ 2.13% ] AKBA - Interest Expense Margin, Last 5 years
2.13%
Minimum
Sep 30, 2020
13.81%
Maximum
Jun 30, 2025
6.49%
Average
5.9%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.63% with a standard deviation of 2.2%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.49% |
| average | 1.63% |
| median | 0.79% |
| std | 2.2% |